Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ARQT

Arcutis Biotherapeutics Inc

May 27 • 04:00PM ET

21.15

+0.04 0.19 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: KRYS MANE ORKA BMRN RYTM VKTX INCY AXSM MDGL NBIX

| Held by: XBI VTI IWM VXF IWO IBB VTWO SCHA VHT FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.03	Insider Own	11.72%	Shs Outstand	125.04M	Perf Week	8.46%
Market Cap	2.65B	Forward P/E	19.79	EPS next Y	1.07	Insider Trans	-1.79%	Shs Float	110.42M	Perf Month	-9.69%
Enterprise Value	2.54B	PEG	-	EPS next Q	0.04	Inst Own	98.39%	Short Float	15.89%	Perf Quarter	-21.70%
Income	-2.38M	P/S	6.37	EPS this Y	253.13%	Inst Trans	1.96%	Short Ratio	11.30	Perf Half Y	-28.28%
Sales	415.62M	P/B	13.95	EPS next Y	436.89%	ROA	-0.59%	Short Interest	17.55M	Perf YTD	-27.17%
Book/sh	1.52	P/C	11.79	EPS next 5Y	-	ROE	-1.43%	52W High	31.77 -33.43%	Perf Year	49.58%
Cash/sh	1.79	P/FCF	98.27	EPS past 3/5Y	71.80% 49.34%	ROIC	-0.80%	52W Low	12.72 66.27%	Perf 3Y	151.79%
Dividend Est.	-	EV/EBITDA	411.67	Sales past 3/5Y	367.27% -	Gross Margin	90.94%	Volatility	4.36% 5.46%	Perf 5Y	-19.37%
Dividend TTM	-	EV/Sales	6.10	EPS Y/Y TTM	98.21%	Oper. Margin	0.77%	ATR (14)	1.10	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.46	Sales Y/Y TTM	95.29%	Profit Margin	-0.57%	RSI (14)	45.11	Recom	1.25
Dividend Gr. 3/5Y	- -	Current Ratio	2.68	EPS Q/Q	56.09%	SMA20	-2.19%	Beta	1.53	Target Price	34.62
Payout	-	Debt/Eq	0.60	Sales Q/Q	60.07%	SMA50	-6.66%	Rel Volume	0.96	Prev Close	21.11
Employees	354	LT Debt/Eq	0.56	Earnings	May 06 AMC	SMA200	-9.63%	Avg Volume	1.55M	Price	21.15
IPO	Jan 31, 2020	Option/Short	Yes / Yes	EPS/Sales Surpr.	-39.97% 1.66%	Trades		Volume	1,504,150	Change	0.19%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)